Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis

Invasive fungal diseases (IFD) still cause substantial morbidity and mortality, and new therapeutic approaches are urgently needed. Recent data suggest a benefit of checkpoint inhibitors (ICI). We report the case of a diabetic patient with refractory IFD following a SARSCoV-2 infection treated by IC...

Descripción completa

Detalles Bibliográficos
Autores principales: Serris, Alexandra, Ouedrani, Amani, Uhel, Fabrice, Gazzano, Marianne, Bedarida, Vincent, Rouzaud, Claire, Bougnoux, Marie-Elisabeth, Raphalen, Jean-Herlé, Poirée, Sylvain, Lambotte, Olivier, Martin-Blondel, Guillaume, Lanternier, Fanny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199385/
https://www.ncbi.nlm.nih.gov/pubmed/35720319
http://dx.doi.org/10.3389/fimmu.2022.900522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199385/
https://www.ncbi.nlm.nih.gov/pubmed/35720319
http://dx.doi.org/10.3389/fimmu.2022.900522

Ejemplares similares